Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Variables associated with patient activation in persons with multiple sclerosis.
Overview of treatment options in multiple sclerosis.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
Individual variability in speed of information processing: An index of cognitive impairment in multiple sclerosis.
Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] (RECYCLINE)
MS Treatment Is on the Cusp of Something Big: On the Cusp of Something Big?
Natalizumab treatment reduces L-selectin (CD62L) in CD4+ T cells.
Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS?
Subcortical atrophy and cognition: Sex effects in multiple sclerosis.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis (PROMESS)
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, th17- and activated B-cells and correlates with progression.
The role of mitochondria in axonal degeneration and tissue repair in MS.
The unwavering commitment of regulatory T cells in the suppression of autoimmune encephalomyelitis: Another aspect of immune privilege in the CNS.
Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway.
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
Axonal transport analysis using Multitemporal Association Tracking.
Trial watch: Chemotherapy with immunogenic cell death inducers.
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.

Pages